Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ReutersBiz Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::15110357.png) Reuters Business [@ReutersBiz](/creator/twitter/ReutersBiz) on x 2.9M followers
Created: 2025-07-07 14:45:00 UTC

WATCH: Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for market share, data from research firm Pharmarack shows

![](https://pbs.twimg.com/amplify_video_thumb/1942224608176017408/img/zLoIaruNXVE6I2op.jpg)

XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942233392923181381/c:line.svg)

**Related Topics**
[$novcde](/topic/$novcde)
[novo](/topic/novo)
[india](/topic/india)
[drugs](/topic/drugs)
[eli lilly](/topic/eli-lilly)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/ReutersBiz/status/1942233392923181381)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ReutersBiz Avatar Reuters Business @ReutersBiz on x 2.9M followers Created: 2025-07-07 14:45:00 UTC

WATCH: Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for market share, data from research firm Pharmarack shows

XXXXXX engagements

Engagements Line Chart

Related Topics $novcde novo india drugs eli lilly stocks healthcare

Post Link

post/tweet::1942233392923181381
/post/tweet::1942233392923181381